Intra-Cellular Therapies

💊 Neuropharmaceuticals· 📍 New York, USA

Overview

Intra-Cellular Therapies is a biopharmaceutical company focused on CNS disorders, best known for Caplyta (lumateperone), an FDA-approved treatment for schizophrenia and bipolar depression. Their drug discovery platform targets intracellular signaling pathways in neurons.

More in Neuropharmaceuticals

Cortexyme Inc.

San Francisco, CA, USA

Neuralstem Inc.

Germantown, MD, USA

Neurogenix Therapeutics

Basel, Switzerland

Acadia Pharmaceuticals

San Diego, USA

Acer Therapeutics

Newton, MA, USA

Praxis Precision Medicine

Cambridge, MA, USA

Latest industry news

China Performs World's First Commercial BCI Implant, Marking a Pivotal Moment in the Global Brain-Computer Interface Race

2026-07-16 · Industry

NIH Confirms Brain-Computer Device Restores Speech in Human Patient

2026-07-15 · Research

Neurovalens Wins FDA Approval for Wearable PTSD Therapy Aimed at US Veterans

2026-07-14 · Policy

BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets

2026-07-13 · Funding

Company details

Is this your company?

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Claim & upgrade listing

Advertise

Reach neurotech professionals

Newsletter sponsorships, featured listings, and sponsored articles.

View packages →